News & Analysis on Clinical Trial Services & Contract Research And Development
An academic clinical research centre that claims CROs markedly increase costs and reduce trial monitoring to box ticking, statements disputed by ACRO, has described its adoption of an in-house system.
Biogen Idec has started shedding development programmes to stay in line with the restructuring plan and job cuts it announced earlier this month.
The USP is building a database of counterfeit essential medicines to support international drug procurement organisations, such as WHO, and the timely sharing of information between national regulators.
According to IMS Health Research, US sales of oncology drugs are slowing despite more firms promising exciting cancer drug developments.
The HIV company, ViiV, set up by GlaxoSmithKline and Pfizer in 2009, might be spun off and floated in an initial public offering.
Clinical Research Advantage (CRA) is introducing its services to the Las Vegas market by opening eight new offices in the region to help trial sponsors bring drugs to market quicker and more effectively.
PRA International says its new bioanalytical services laboratory in Lenexa, Kansas offers clinical customers streamlined services.